Statement from NHS West Hampshire CCG and Wessex AHSN: Digitalising RESTORE2TM and RESTORE2TM mini
We understand that a number of organisations across the country are exploring the creation of digital versions of the nationally recognised RESTORE2TM tool. This has been brought to the forefront of consciousness in light of the recent COVID-19 pandemic, the impact of the virus within care/nursing homes and the speed at which solutions need to be developed to support this vital area of healthcare.
NHS West Hampshire CCG is keen to work with developers to ensure that all care/nursing homes have access to a digital version of RESTORE2 TM and RESTORE2 TM mini as quickly as possible. When considering this it is important to recognise RESTORE2TM has been trademarked by NHS West Hampshire CCG in order to ensure consistency across discrete implementations. This consistency applies to both the look and feel of the tool as well as the clinical pathways that will be impacted by a transition to a digital platform.
NHS West Hampshire CCG, with the help of Wessex AHSN, is developing a Market Specification for both RESTORE2TM and RESTORE2TM mini. This Market Specification will enable organisations to develop digital solutions that remain familiar for those using the existing RESTORE2TM tool and RESTORE2TM mini tools across the UK, whilst ensuring the clinical safety of patient pathways after the transition to a digital platform. Through establishing this specification, it is anticipated that care providers will adopt digital versions of the RESTORE2TM tool more rapidly due to the assurance it provides.
We hope to create this Market Specification by the end of May 2020 and request that organisations do not progress their own independent adaptations of the RESTORE2TM tool without the express permission of NHS West Hampshire CCG in advance of this specification being published. If you have any queries, please direct them to email@example.com (West Hampshire CCG).